Literature DB >> 8352234

Hemostatic study before onset of disseminated intravascular coagulation.

H Wada1, K Minamikawa, Y Wakita, T Nakase, T Kaneko, M Ohiwa, S Tamaki, A Deguchi, Y Mori, K Deguchi.   

Abstract

Early diagnosis is necessary for the treatment of disseminated intravascular coagulation (DIC), but criteria for the stage preceding the diagnosis of DIC (pre-DIC) have not yet been established. To clarify hemostatic abnormalities that occur before the onset of DIC, we performed hemostatic studies in 117 patients within at least a week before the onset of DIC (pre-DIC), in 237 patients with DIC, and in 50 patients without DIC or pre-DIC (non-DIC). Levels of FDP, PT, and fibrinogen, and platelet counts were significantly abnormal after the onset of DIC, but not before. Thrombin-antithrombin III complex (TAT), plasmin-alpha 2 plasmin inhibitor complex (PIC), and FDP-D-dimer levels were significantly higher before the onset of DIC compared to the non-DIC patients. Hemostatic abnormalities were observed within a week before the onset of DIC. Monitoring the plasma levels of TAT, PIC, and FDP-D-dimer might be useful for the diagnosis of a pre-DIC condition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352234     DOI: 10.1002/ajh.2830430306

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.

Authors:  Kunimoto Ichikawa; Yoko Edahiro; Akihiko Gotoh; Kazuhide Iiduka; Norio Komatsu; Michiaki Koike
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

2.  Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis.

Authors:  Jong Hwa Lee; Jae Woo Song; Kyung Soon Song
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

Review 3.  Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines.

Authors:  Hideo Wada; Takeshi Matsumoto; Yoshiki Yamashita
Journal:  J Intensive Care       Date:  2014-02-20

4.  Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.

Authors:  Guo Chen; Jian-Qing He
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  Risk factors and treatments for disseminated intravascular coagulation in neonates.

Authors:  Hayato Go; Hitoshi Ohto; Kenneth E Nollet; Nozomi Kashiwabara; Kei Ogasawara; Mina Chishiki; Shun Hiruta; Ichiri Sakuma; Yukihiko Kawasaki; Mitsuaki Hosoya
Journal:  Ital J Pediatr       Date:  2020-04-29       Impact factor: 2.638

6.  Disseminated Intravascular Coagulation after Surgery for Facial Injury.

Authors:  Hisashi Ozaki; Hirohiko Tachibana; Shigeo Ishikawa; Kazuyuki Yusa; Kenichirou Kitabatake; Mitsuyoshi Iino
Journal:  Case Rep Dent       Date:  2016-05-30

7.  Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs.

Authors:  Kenji Rimpo; Aki Tanaka; Masayasu Ukai; Yuichi Ishikawa; Miyuki Hirabayashi; Toshihiro Shoyama
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.